Rare diseases
Investigational molecules
Locations
A Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease
The NetherlandsThe NetherlandsEfficacy of Enfortumab Vedotin plus Pembrolizumab in Adult Patients with Muscle‑Invasive Bladder Cancer Using a Bladder‑Sparing Response‑Adapted Approach
The NetherlandsEfficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
The NetherlandsStudy of subcutaneous anifrolumab pharmacokinetics, pharmacodynamics and safety in children aged 5 to <18 years with systemic lupus erythematosus
The NetherlandsStudy of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy
The NetherlandsEfficacy and Safety of Intranasal Cenegermin in Adults with Non‑Arteritic Anterior Ischemic Optic Neuropathy (NAION)
The NetherlandsEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
The NetherlandsIntranasal remestemcel therapy for newborns with hypoxic‑ischemic brain injury: a phase II placebo‑controlled trial
The NetherlandsMicronised progesterone luteal-phase support improves live birth rates in women with unexplained infertility
The NetherlandsEvaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients
The NetherlandsAnakinra for Sepsis and Hyperinflammation in Pediatric Cancer Patients in the Intensive Care Unit
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
